JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
BBOT - Bridgebio Oncology Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary BBOT Stock
Financials
Financials BBOT Stock
Loading...
Loading...
Income Statement
Income Statement BBOT Stock
Balance Sheet
Balance Sheet BBOT Stock
Cash Flow Statement
Cash Flow Statement BBOT Stock
Loading...
Loading...
Home
Stocks
Bridgebio Oncology Therapeutics, Inc. (BBOT)
Financials
Financials of BBOT
Loading...
Loading...
Loading...
Loading...
BBOT Financials - Bridgebio Oncology Therapeutics Income & Cash Flow | Ledgeburg
Revenue
N/A
Operating Income
$-145.819M
Net Income
$-134.044M
Share Count (Basic)
31.144775M
Operating Cash Flow
$-113.894M
Free Cash Flow
$-114.5M
Cash And Short-Term Equivalents
$425.46M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
No data available
Revenue $USD
No data available
Annual
Quarterly
Net Income $USD
-100M
-50M
0
FY2023
FY2024
FY2025
Annual
Quarterly
Margins
No data available
Margins
No data available
Net Income $USD
-45M
-40M
-35M
-30M
-25M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26